Signals are promoted only when they change a judgment, strengthen a convergence, or create a time-sensitive advisory move.
Most recent successful retrieval (partial coverage): 03 Oct, 05:07 Beirut Packet generated 03 Oct, 05:07 Beirut Page built 03 October 2026, 05:07 Beirut
1do now
10open decisions
12signals in view
12precursors
72sources tracked
3stale · 4 errors
Today
Recent source-dated developments; a signal alone does not change advice
NEWLY DETECTED03 Oct, 05:07
ClinicalTrials.gov: Coronary and Myocardial Evaluation by Cardiac CT for Acute Myocardial Infarction
trial registration or update; not evidence of efficacy
Acute myocardial infarction (AMI) remains a major cause of mortality and morbidity worldwide. Although percutaneous coronary intervention (PCI) combined with guideline-directed medical therapy has substantially improved survival, many patients continue to experience adverse cardiovascular events after…
Why you may careCould matter to agent workflows if the reported task success, human handoff, cost, and operating limits hold up.
Next checkCheck the measured outcome, comparison, limits, and whether it applies to a decision you own. Until then, treat it as a lead.
NEWLY DETECTED03 Oct, 05:07
ClinicalTrials.gov: Screening and Intervention of MASLD in Children
trial registration or update; not evidence of efficacy
Non-alcoholic fatty liver disease (NAFLD) in children and adolescents has recently been renamed metabolic dysfunction-associated steatotic liver disease (MASLD). It has become one of the leading chronic liver diseases in children. The prevalence of MASLD is 6.3% among the general pediatric population and 40.4%…
Why you may careA reported deployment case may be relevant; its results may not transfer to your workflow or operating conditions.
Next checkCheck the measured outcome, comparison, limits, and whether it applies to a decision you own. Until then, treat it as a lead.
NEWLY DETECTED03 Oct, 05:07
ClinicalTrials.gov: Improving Balance and Energetics of Walking Using a Hip Exoskeleton
trial registration or update; not evidence of efficacy
Robotic lower limb exoskeletons aim to improve or augment limb functions. Automatic modulation of robotic assistance is very important because it can increase the assistive outcomes and guarantee safety when using exoskeletons. However, this automatic assistance adjustment is challenging due to person-to-person and…
Why you may careCould improve how you evaluate or monitor agents; the method and results need independent checking before adoption.
Next checkCheck the measured outcome, comparison, limits, and whether it applies to a decision you own. Until then, treat it as a lead.
WATCHDECISION PROPOSED
Watch MOBA-VL v2 as an author-reported, task-specific VLM benchmark result; do not infer general agent reliability or change production routing.
The authors describe a 9B vision-language model trained with event-localized multi-turn reinforcement learning, a dataset of 860 professional matches, and a held-out tournament benchmark. This is a testable evaluation-method signal, but the paper page is not independent replication.
Say this to MJ's agent evaluation and research automation workMonitor the promised code/data release and seek an independent reproduction on the same held-out task definition before using the reported scores in an advisory or routing decision.
Next moveCheck for the stated code/data release and one independent reproduction with disclosed task splits, baselines, and human correction burden.
What would change this judgment?
An independent reproduction fails to recover the reported gains under comparable held-out tournament conditions, or the dataset/split or baseline comparison is not equivalent.
Labs, models & tooling34/34 live
100%
Research13/13 live
100%
Expert intelligence6/6 live
100%
Policy, capital & adoption13/17 live
76%
Talent2/2 live
100%
Grok / X precursor scoutLatest attempt 24 Sep, 10:53 Beirut
{
"abstract": "This final rule implements the Global Benchmark for Efficient Drug Pricing Model (GLOBE Model), a new mandatory Medicare payment model under section 1115A of the Social Security Act. The GLOBE Model will test whether a payment model that uses an alternative method for calculating Medicare Part B drug…
capabilitydeploymentconstraintspolicy
Federal Register document metadata and abstract; underlying action requires review
arXiv:2610.00223v1 Announce Type: new Abstract: As ever larger language models grow more ubiquitous, it is crucial to consider their environmental impact. Characterised by extreme size and resource use, recent generations of models have been criticised for their voracious appetite for compute, and thus significant carbon…
arXiv:2610.01297v1 Announce Type: new Abstract: Ireland's smart metering programme records electricity use at 30-minute resolution, with smart meters installed in over 80\% of households as of late 2025. While this is useful for billing of smart, time-of-use tariffs, it is too coarse to capture use of domestic appliances. We…
An agent can finish a task and still take an inefficient path. A failed search can trigger another search. A truncated file read can lead to a command fetching... An agent can finish a task and still take an inefficient path. A failed search can trigger another search. A truncated file read can lead to a command fetching the…
arXiv:2609.38428v1 Announce Type: new Abstract: Real-time commentary for Multiplayer Online Battle Arena (MOBA) esports requires a vision-language model (VLM) to narrate a live match second by second, both fluently and accurately. Existing streaming VLMs sound natural but often miss key events such as kills and objectives.…
arXiv:2609.38512v1 Announce Type: new Abstract: Voice agents in production must handle several requests, background speech, and customers who lose patience. We introduce VAmoS Energy, a benchmark that combines these challenges in 100 calls about utility billing and payment assistance. Each caller makes two to four requests.…
arXiv:2609.39384v1 Announce Type: new Abstract: Long-horizon surgical assistance requires humanoid robots to coordinate with evolving human activities while maintaining safety across planning and execution. We present RoboAssist, an agent-based framework for interactive human-humanoid planning that integrates workflow…
Acute myocardial infarction (AMI) remains a major cause of mortality and morbidity worldwide. Although percutaneous coronary intervention (PCI) combined with guideline-directed medical therapy has substantially improved survival, many patients continue to experience adverse cardiovascular events after revascularization,…
capabilitydeploymentconstraints
trial registration or update; not evidence of efficacy
Non-alcoholic fatty liver disease (NAFLD) in children and adolescents has recently been renamed metabolic dysfunction-associated steatotic liver disease (MASLD). It has become one of the leading chronic liver diseases in children. The prevalence of MASLD is 6.3% among the general pediatric population and 40.4% among…
capabilitydeploymentconstraints
trial registration or update; not evidence of efficacy
Robotic lower limb exoskeletons aim to improve or augment limb functions. Automatic modulation of robotic assistance is very important because it can increase the assistive outcomes and guarantee safety when using exoskeletons. However, this automatic assistance adjustment is challenging due to person-to-person and…
capabilitydeploymentconstraints
trial registration or update; not evidence of efficacy
A safety certificate for a clinical AI promises that no more than a stated fraction of the answers it releases carry a defect that would change care. That promise is computed from past cases a clinician marked safe, and clinicians miss things. A missed defect is not filed as a disagreement, it is filed as a safe case, so the…
capabilitydeploymentconstraints
medRxiv preprint; not peer reviewed and not clinical advice
Highlights 779 PRs from 227 contributors. New models Model Type Cookbook DeepSeek-V4.1 Flash LLM / VLM link GigaChat 3.5 LLM / VLM link IQuest-Q1 LLM / VLM link MiMo-V2.6 / MiMo-V2.6-Pro LLM / VLM link Ling-3.0-flash-VL LLM / VLM link DiffusionGemma Diffusion link Qwen-Image 2.1 Diffusion link Anima Base v1.0 Diffusion link…
capabilitydeployment
repository release Atom feed; release claims unverified
Reviewed developments
Proposed decisions, not executed actions. Breakthrough verification is not yet established.
DECISION PROPOSED · 17 Sep, 08:20
Upgrade llama.cpp before the next Apple Silicon MoE evaluation.
Decision rationale; primary evidence not yet reviewed.
Recorded rationaleThe release fixes a Metal path that can turn large activations into NaNs. Any earlier MoE result on that path may be unreliable.
Reviewed evidenceDecision rationale; primary evidence not yet reviewed.
DECISION PROPOSED · 17 Sep, 08:20
Do not adopt Mimir 1B from parameter count alone.
Decision rationale; primary evidence not yet reviewed.
Recorded rationalellama.cpp reports roughly four times the decode work of an equal-width dense model and about 3 GB of F16 KV cache at 4K context.
Reviewed evidenceDecision rationale; primary evidence not yet reviewed.
DECISION PROPOSED · 17 Sep, 08:20
Treat Groq 3 LPX power-efficiency claims as a future infrastructure signal, not available GCC capacity.
Decision rationale; primary evidence not yet reviewed.
Recorded rationaleThe vendor framing strengthens the case that power per useful token is the bottleneck, but it provides no dated GCC commissioning or customer-access evidence.
Reviewed evidenceDecision rationale; primary evidence not yet reviewed.
Decision queue
Every item has a next move and a condition that can overturn it.
DO NOWDECISION PROPOSED
Upgrade llama.cpp before the next Apple Silicon MoE evaluation.
The release fixes a Metal path that can turn large activations into NaNs. Any earlier MoE result on that path may be unreliable.
Say this to AI implementation teams running local modelsPause comparisons made on the affected Apple Silicon path. Re-run one representative task on the fixed build before treating earlier quality or latency results as decision-grade.
Next movePin a build at or after b10994, rerun one representative MoE prompt, and compare output plus latency with the previous build.
What would change this judgment?
The affected mul_mm_id path was not used by our model or backend configuration.
WATCHDECISION PROPOSED
Do not adopt Mimir 1B from parameter count alone.
llama.cpp reports roughly four times the decode work of an equal-width dense model and about 3 GB of F16 KV cache at 4K context.
Say this to CIOs and private-AI operatorsA small parameter count is not a low operating cost. Require cost per successful task, memory use and supervision time before choosing this model for private workflows.
Next moveWait for prefix-LM support and an independent cost-per-success result before spending evaluation time.
What would change this judgment?
A reproducible task test shows enough accuracy gain to offset the reported memory and decode costs.
WATCHDECISION PROPOSED
Treat Groq 3 LPX power-efficiency claims as a future infrastructure signal, not available GCC capacity.
The vendor framing strengthens the case that power per useful token is the bottleneck, but it provides no dated GCC commissioning or customer-access evidence.
Say this to GCC sovereign, infrastructure and data-center leadersPlan around power per useful AI outcome and verified access dates. Do not count announced silicon as sovereign capacity until an operating deployment exposes customer access and independent performance data.
Next moveTrack independent watts-per-token and customer-access evidence tied to an operating Vera Rubin deployment.
What would change this judgment?
A dated operational deployment exposes customer access and independently measured performance per watt.
WATCHDECISION PROPOSED
Watch Anthropic ART as a research-automation case; do not treat as a validated application.
The described pipeline links parallel genomic search to candidate triage and human lab testing, but ART function remains unknown and independent validation is absent.
Say this to USEK research and AI workflow advisorsTreat this as a workflow signal: agents can search and rank candidates, while human scientists retain experimental validation. Do not infer a usable biological tool or general autonomous discovery from this case.
Next moveReview the technical report and seek independent replication; measure cost, expert review time, candidate yield and repeatability.
What would change this judgment?
The technical report or independent replication fails to confirm the reported RNA expression or novelty, or comparable searches fail to reproduce the candidate workflow.
WATCHDECISION PROPOSED
Watch Ringg's production pattern; do not treat the customer-story performance figures as independently validated.
OpenAI describes task-based model routing, specialist agents, offline evaluation, staged rollout, live endpoint monitoring and human escalation in a deployed multi-channel service workflow.
Say this to MJ's agent workflows, USEK applied research, and GCC service deploymentsFor an agent deployment, pair task routing and specialist steps with offline evaluation, gradual release, endpoint health checks and clear human handoff. Treat the reported resolution, CSAT and savings figures as vendor/customer claims until independently reproduced.
Next moveAsk for independently measured task mix, resolution denominator, escalation rate, language-specific quality, cost per completed task and post-deployment monitoring evidence.
What would change this judgment?
Independent customer or auditor data shows that completion rates, quality, or cost improvements do not generalize beyond selected workloads or fail to include human handling costs.
WATCHDECISION PROPOSED
Track AnewDDE as a research-automation signal; do not recommend adoption from the preprint claim alone.
A bioRxiv preprint describes an agentic closed-loop drug-discovery workflow connecting structure, affinity, design and experiment selection. It reports 10.7% success for single-digit-nanomolar binders in one nanobody campaign; this remains author-reported evidence.
Say this to USEK research automation and MJ agent workflowsPotentially relevant to a bounded literature or lab-workflow review if methods and data substantiate the claim; no deployment decision yet.
Next moveInspect full methods and results, especially campaign denominator, assay protocol, controls, and availability of data/code.
What would change this judgment?
Full methods fail to support the reported binder yield, the result is not reproducible, or performance depends on a selected campaign that does not generalize.
WATCHDECISION PROPOSED
Use claude-opus-5-5 for approved premium Claude work after confirming the exact provider model ID; evaluate task-level quality, time, and spend before broadening its role.
Anthropic announced Opus 5.5 on Sep 22 and claims 40% lower typical token-billed running cost than Opus 5. The official model page gives the API identifier claude-opus-5-5. Its quality and cost claims remain vendor-reported.
Say this to MJ agent workflows and Claude routingPin claude-opus-5-5 for eligible premium tasks only after checking the active provider supports that exact ID; record outcome and measured usage against a fixed task baseline.
Next moveVerify exact provider model ID and run one bounded representative task comparison against the current Opus baseline, recording quality, elapsed time, token use and billed cost.
What would change this judgment?
Provider does not expose the exact model ID, or a task-matched comparison shows worse quality or no worthwhile end-to-end cost/time benefit.
WATCHDECISION PROPOSED
Treat OpenRouter's DeepSeek Latest price/catalog revision as a route-specific cost signal; verify an exact pinned model/version before updating any cost assumption or routing decision.
OpenRouter's current pages map Pro Latest to V4 Pro 0813 at $3.78/M output tokens and Flash Latest to V4.1 Flash at $0.60/M. The prior catalog snapshot differs materially, but latest aliases and slight page/API discrepancies prevent a like-for-like tariff conclusion.
Say this to MJ agent workflows, USEK research, and GCC deployment cost planningBefore relying on a DeepSeek Latest route for cost estimates, pin the exact model version and check the current provider/router tariff against the earlier catalog snapshot. No routing change is proposed from this listing alone.
Next moveCompare the pinned V4 Pro 0813 and V4.1 Flash tariffs with any direct-provider price sheet and calculate cost per successful representative task before changing a budget or route.
What would change this judgment?
The apparent increase disappears when comparing the same pinned model version, or direct provider pricing and a fixed-task cost-per-success measurement show no meaningful change for MJ's workload.
WATCHDECISION PROPOSED
Watch VAmoS as a preprint benchmark lead; do not change production routing or infer real-world voice-agent reliability from its reported simulations.
The authors report completion from 17.3% to 44.7% across 14 voice stacks and a large drop with background TV in a 100-call simulated utility-billing benchmark. These claims highlight a testable reliability constraint but remain unreviewed and unreplicated.
Say this to MJ agent workflows and voice-agent deployment adviceUse the benchmark as a prompt to test multi-request completion, background speech, action correctness and caller verification on a fixed representative task set. The preprint alone does not establish production failure rates.
Next moveMonitor for released benchmark materials and an independent reproduction; if available, run one bounded task comparison that records success, corrections and elapsed time.
What would change this judgment?
Independent reproduction shows materially higher completion under comparable multi-request and background-speech conditions, or the simulation fails to transfer to relevant real-call tasks.
WATCHDECISION PROPOSED
Watch MOBA-VL v2 as an author-reported, task-specific VLM benchmark result; do not infer general agent reliability or change production routing.
The authors describe a 9B vision-language model trained with event-localized multi-turn reinforcement learning, a dataset of 860 professional matches, and a held-out tournament benchmark. This is a testable evaluation-method signal, but the paper page is not independent replication.
Say this to MJ's agent evaluation and research automation workMonitor the promised code/data release and seek an independent reproduction on the same held-out task definition before using the reported scores in an advisory or routing decision.
Next moveCheck for the stated code/data release and one independent reproduction with disclosed task splits, baselines, and human correction burden.
What would change this judgment?
An independent reproduction fails to recover the reported gains under comparable held-out tournament conditions, or the dataset/split or baseline comparison is not equivalent.
Lead / lag scoreboard
63 matched items. Baseline discoveries are shown but never claimed as wins.
VERIFIED LEAD105h ahead
Self-Play Pretraining with Zero Data
Compared with Welcome to September 29, 2026. Prospective timing is measurable.
VERIFIED LEAD80h ahead
Introducing MentalHealthBench
Compared with Welcome to September 27, 2026. Prospective timing is measurable.
VERIFIED LEAD80h ahead
Contrastive Language Models
Compared with Welcome to September 27, 2026. Prospective timing is measurable.
VERIFIED LEAD59h ahead
Promising discoveries about the potential for life on one of Saturn’s icy moons
Compared with Welcome to September 29, 2026. Prospective timing is measurable.
VERIFIED LEAD43h ahead
Introducing Astra for Law
Compared with Welcome to September 20, 2026. Prospective timing is measurable.
VERIFIED LEAD43h ahead
Sep 18, 2026 Announcements Partnering with Accenture on embedded evaluation
Compared with Welcome to September 20, 2026. Prospective timing is measurable.
{
"abstract": "This final rule implements the Global Benchmark for Efficient Drug Pricing Model (GLOBE Model), a new mandatory Medicare payment model under section 1115A of the Social Security Act. The GLOBE Model will test whether a payment model that uses an alternative method for calculating Medicare Part B drug…
capabilitydeploymentconstraintspolicy
Federal Register document metadata and abstract; underlying action requires review
arXiv:2610.00223v1 Announce Type: new Abstract: As ever larger language models grow more ubiquitous, it is crucial to consider their environmental impact. Characterised by extreme size and resource use, recent generations of models have been criticised for their voracious appetite for compute, and thus significant carbon…
arXiv:2610.01297v1 Announce Type: new Abstract: Ireland's smart metering programme records electricity use at 30-minute resolution, with smart meters installed in over 80\% of households as of late 2025. While this is useful for billing of smart, time-of-use tariffs, it is too coarse to capture use of domestic appliances. We…
arXiv:2609.38428v1 Announce Type: new Abstract: Real-time commentary for Multiplayer Online Battle Arena (MOBA) esports requires a vision-language model (VLM) to narrate a live match second by second, both fluently and accurately. Existing streaming VLMs sound natural but often miss key events such as kills and objectives.…
arXiv:2609.38512v1 Announce Type: new Abstract: Voice agents in production must handle several requests, background speech, and customers who lose patience. We introduce VAmoS Energy, a benchmark that combines these challenges in 100 calls about utility billing and payment assistance. Each caller makes two to four requests.…
arXiv:2609.39384v1 Announce Type: new Abstract: Long-horizon surgical assistance requires humanoid robots to coordinate with evolving human activities while maintaining safety across planning and execution. We present RoboAssist, an agent-based framework for interactive human-humanoid planning that integrates workflow…
Acute myocardial infarction (AMI) remains a major cause of mortality and morbidity worldwide. Although percutaneous coronary intervention (PCI) combined with guideline-directed medical therapy has substantially improved survival, many patients continue to experience adverse cardiovascular events after revascularization,…
capabilitydeploymentconstraints
trial registration or update; not evidence of efficacy
Non-alcoholic fatty liver disease (NAFLD) in children and adolescents has recently been renamed metabolic dysfunction-associated steatotic liver disease (MASLD). It has become one of the leading chronic liver diseases in children. The prevalence of MASLD is 6.3% among the general pediatric population and 40.4% among…
capabilitydeploymentconstraints
trial registration or update; not evidence of efficacy
Robotic lower limb exoskeletons aim to improve or augment limb functions. Automatic modulation of robotic assistance is very important because it can increase the assistive outcomes and guarantee safety when using exoskeletons. However, this automatic assistance adjustment is challenging due to person-to-person and…
capabilitydeploymentconstraints
trial registration or update; not evidence of efficacy
A safety certificate for a clinical AI promises that no more than a stated fraction of the answers it releases carry a defect that would change care. That promise is computed from past cases a clinician marked safe, and clinicians miss things. A missed defect is not filed as a disagreement, it is filed as a safe case, so the…
capabilitydeploymentconstraints
medRxiv preprint; not peer reviewed and not clinical advice
This is a summary of a longer report on our website. Anthropic’s Dario Amodei has described a future “country of geniuses in a datacenter”, but could we actually see AI spitting out a country’s worth of labor in the next few years? AI companies are shelling out hundreds of billions of dollars each year on chips and data…
Cardiovascular diseases (CVD) are associated with high healthcare costs,as well as are a leading cause of mortality and hospitalizations. One of CVDs is a heart failure which may be associated with dyssynchrony of contraction of right and left ventricle. Chance for group of patients whose pharmacotherapy is not enough is…
capabilitydeploymentconstraints
trial registration or update; not evidence of efficacy
Hypothesis register
Amber means the prerequisite still lacks reviewed evidence.
agent-reliability13 days overdue
When can agents complete our multi-step work with fewer interventions?
Reliable extended task completion5 reviewed
Lower human correction time1 reviewed
Independent task reproduction0 reviewed
Next discriminating observationIndependent fixed-task results reporting failures, retries and human minutes
open-model-economics13 days overdue
When do deployable open models become viable for our private workflows?
Usable license and released weights1 reviewed
Fits available memory1 reviewed
Acceptable quality at fully loaded cost1 reviewed
Next discriminating observationA reproducible cost-per-success comparison under our hardware constraints
gcc-compute-bottlenecks13 days overdue
Does announced sovereign compute translate into usable capacity?
Delivered equipment0 reviewed
Commissioned power1 reviewed
Accessible operational service0 reviewed
Next discriminating observationDated commissioning and customer-access evidence, not another capacity pledge
research-automation13 days overdue
Which scientific workflows now produce independently validated results?
Reliable execution0 reviewed
Affordable validated result0 reviewed
Experimental access2 reviewed
Independent scientific validation0 reviewed
Repeat adoption0 reviewed
Next discriminating observationIndependent replication including total cost and expert verification time
eval-credibility13 days overdue
Which frontier capability claims survive independent evaluation and provenance scrutiny?
Evaluator independence disclosed0 reviewed
Task and harness equivalence established0 reviewed
Independent reproduction1 reviewed
Contamination and privileged-access risks addressed0 reviewed
Next discriminating observationA primary evaluation artifact and an independent reproduction using the same task definition
This page is a decision surface, not a feed reader. “Decision proposed” records an advisory recommendation; it does not prove execution. Repeated coverage does not count as independent evidence. Unknown measurements remain unknown. Email inventory is incomplete; this page does not represent a complete account inventory.